We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Online Monitoring of Cellular Metabolism Used to Evaluate Drug Candidates

By Biotechdaily staff writers
Posted on 15 Oct 2007
The never-ending search for new drugs demanded development of reliable and cost-effective methods for monitoring the effects of candidate compounds on living cells and tissues.

Towards this end the drug developer Solvay Pharmaceuticals GmbH (Hannover, Germany) has signed a service contract with Bionas GmbH (Rostock, Germany), specialists in analytical systems and services for in vitro profiling of cellular metabolic activity.

Under the terms of the agreement the Bionas 2500 analyzing system will be used to profile several drug candidates identified in the context of Solvay´s obesity research program. More...
The Bionas 2500 system permits monitoring of both acute and chronic effects of drug candidates in different cell types thanks to a proprietary perfusion system. It is a bench-top instrument that allows the simultaneous, label-free and high-content analysis of three metabolic parameters, such as acidification, oxygen consumption, and adhesion of living cells. Readouts are performed continuously and can be monitored online.

"The Bionas instrument is a valuable tool for compound ranking and helps us select the most promising compounds for further development,” said Dr. Michael Firnges, an investigator at Solvay Pharmaceuticals GmbH.


Related Links:
Solvay Pharmaceuticals GmbH
Bionas GmbH

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Automated Clinical Chemistry Analyzer
Envoy 500+
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.